Considerations in Demonstrating Interchangeability With a Reference Product: Update
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 21, 2024
June 21, 2024
f154845a-a15e-4508-a634-dd22f907a286
Related Documents
Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts
Guidance DocumentJuly 31, 2026Center for Drug Evaluation and Research
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies: Draft Guidance for Industry
Guidance DocumentOctober 29, 2025Center for Drug Evaluation and Research
Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials
Guidance DocumentApril 9, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.